Eli Lilly News

Selecting companies that have consistently strong dividend growth can mean the difference between early retirement and working a lot longer.

With a fresh $12 million investment round , GreenBytes plans to increase the sales and marketing of its data storage arrays that help customers virtualize desktops at low costs.

Shares of Eli Lilly & Co. closed the trading day lower by $0.05 or -0.12% from its previous close.

The investment by Teralys Capital, together with investments by Eli Lilly and Company and other partners, enables a new investment model in Quebec, which will involve the formation by the Fund of single therapeutic asset companies and benefit the entire local life sciences ecosystem of researchers, entrepreneurs, business partners and service ... (more)

Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men with low levels of testosterone.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Boehringer Ingelheim Corporation and Eli Lilly and Company Release: Jentaduetoa Tablets Recommended for Approval in the Treatment of Adults with Type 2 Diabetes in Europe ... (more)

GlaxoSmithKline Plc will reveal detailed results today on an experimental treatment for diabetes that's part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc., its partner on the drug.

The U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Eli Lilly & Co.

American College of Endocrinology and Eli Lilly and Company Diabetes Offer New Tips to Help People With Diabetes Prepare for Emergencies /PRNewswire/ -- Today, the American College of Endocrinology and Lilly Diabetes launched the "EmPower Diabetes Emergency Plan" a newly designed resource to help people with diabetes prepare for emergency ... (more)

This monthly report series began applying dog dividend methodology to each of eight major market sectors in December.

New Phase 3 Data for Tradjenta Tablets in Black Or African American Patients With Type 2 Diabetes Showed Significant Improvement in Blood Sugar First published trial of a dipeptidyl peptidase-4 inhibitor specifically conducted in black or African American patients with type 2 diabetes RIDGEFIELD, Conn.

From food safety fears, to perceived health benefits, or just the peace of knowing where their meals come from, more Hoosiers are turning to food grown and raised in the ways of generations past.

Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing.

Eli Lilly & Co. said dulaglutide, an investigational treatment for Type 2 diabetes, met a primary endpoint for blood pressure and heart rate effects in a 16-week study.

May 20--Prolor Biotech Inc. has enough cash to conduct late-stage studies of its longer-lasting growth hormone, CEO Dr.

The firm set a "market perform" rating and a $37.00 price target on the stock. Shares of Eli Lilly & Co.

We like companies that have little or no debt, because these companies tend to have long-term competitive advantage.

Jim Simons' Renaissance Technologies hedge fund has just released its 13F , outlining the structure of its investment portfolio.

Eli Lilly & Co. : Jim Cramer ranked this stock a Buy . The stock closed at $40.53, its 52-week high is $42.03, and its 52-week low is $33.75. Oshkosh Corporation : Jim Cramer ranked this stock a Sell .

Shares of Eli Lilly & Co. opened at 40.53 on Friday. Eli Lilly & Co. has a one year low of $33.75 and a one year high of $42.03. The company has a market cap of $45.272 billion and a P/E ratio of 10.50. Eli Lilly & Co.